Becton Dickinson (NYSE:BDX) announced today that it has completed its acquisition of privately held Safety Syringes, a maker of pre-filled, anti-needlestick syringes. BD expects the deal to have a minimal dilutive effect on its fiscal 2013 results. Financial terms of the deal were not disclosed.
The purchase of Safety Syringes is expected to expand on BD's health-care worker's safety technology solutions, particularly for prefilled syringe customers.
According to Claude Dartiguelongue, president of BD's Pharmaceutical Systems, "We are excited about this acquisition, which expands the Company's presence in safety technologies and further demonstrates BD's commitment to developing innovative solutions that help address our customers' unmet needs."
Tim Brugger has no positions in the stocks mentioned above, and neither does The Motley Fool. Motley Fool newsletter services recommend Becton Dickinson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.